Gene therapy to correct defective genes requires efficient gene delive
ry and long-term gene expression. The available vector systems have no
t allowed the simultaneous achievement of both goals. We have develope
d a chimeric viral vector system that incorporates favorable aspects o
f both adenoviral and retroviral vectors. Adenoviral vectors induce ta
rget cells to function as transient retroviral producer cells in vivo.
The progeny retroviral vector particles are then able to stably trans
duce neighboring cells. In this system, the nonintegrative adenoviral
vector is rendered functionally integrative via the intermediate gener
ation of a retroviral producer cell. The chimeric vectors may allow re
alization of the requisite goals for specific gene-therapy application
s.